Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Multiple Myeloma
Interventions
DRUG

Palonosetron

Trial Locations (10)

10021

Cornell Medical Center, New York

19104

University of Pennsylvania, Philadelphia

19111

Fox Chase-Temple, Philadelphia

22031

Fairfax-Northern Virginia Hematology-Oncology PC, Fairfax

27157

Wake Forest Medical Center, Winston-Salem

46107

Indiana Blood and Marrow Transplantation, Beech Grove

75246

Baylor University Blood and Marrow Transplantation, Dallas

77030

MD Anderson Cancer Center, Houston

78229

Texas Transplant Institute, San Antonio

97239

Oregon Health & Science University, Portland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Helsinn Healthcare SA

INDUSTRY

lead

Eisai Inc.

INDUSTRY